An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma.
The prothrombin assay method using the synthetic thrombin-inhibitor MD805 was standardized by fixing the concentrations of MD805 and S-2238 through their extinction coefficients (epsilon 333 for MD805 and epsilon 316 for S-2238). The prothrombin assay was directly proportional to the concentration of plasma up to 200% of the normal level and was not significantly influenced by the variety of three kinds of commercially available tissue thromboplastin preparations. Using plasma from Warfarin-treated patients and healthy volunteers, the correlation was studied between the prothrombin assay and the conventional coagulation tests such as Prothrombin time (INR), Thrombotest and Hepaplastintest (Normotest), and the correlation coefficients of -0.85, 0.81 and 0.94 were obtained respectively. FUT-175 and MD805 in the test plasma hardly affected the prothrombin assay in the concentration ranges which affected remarkably the conventional coagulation tests. These results indicated that the prothrombin assay was useful for monitoring the hyper- or hypoprothrombin state even on anticoagulant therapy. Eighteen healthy volunteers at 18 to 20 years old showed the mean and standard deviation of 0.96 +/- 0.097.
Hijikata-Okunomiya
A
A
School of Allied Medical Sciences, Kobe University, Japan.
Funahara
Y
Y
Opartkiattikul
N
N
D000293:Adolescent; D000328:Adult; D000991:Antithrombins; D001120:Arginine / Q000031:analogs & derivatives; D001550:Benzamidines; D001780:Blood Coagulation Tests / Q000379:methods*; D004151:Dipeptides; D006146:Guanidines; D006801:Humans; D010875:Pipecolic Acids; D011516:Prothrombin / Q000032:analysis*; D013449:Sulfonamides; D014859:Warfarin / Q000097:blood* / Q000627:therapeutic use
D000991:Antithrombins; D001550:Benzamidines; D004151:Dipeptides; D006146:Guanidines; D010875:Pipecolic Acids; D013449:Sulfonamides; D014859:Warfarin; C021129:S 2238; D011516:Prothrombin; D001120:Arginine; C031942:argatroban; C032855:nafamostat